Date of Award:
Master of Science (MS)
Animal, Dairy, and Veterinary Sciences
Brett L. Hurst
Brett L. Hurst
E. Bart Tarbet
Shawn M. Zimmerman
Enterovirus D68 (EV-D68) is a virus that causes respiratory disease. Children are most commonly affected by EV-D68 but immunocompromised adults can also get infected and develop severe disease signs. In 2014, the United States experienced an unprecedented outbreak of EV-D68. Similar outbreaks were also observed in 2016, 2018 and 2022. Interestingly, few EV-D68 infections were observed in 2020, likely due to public health measures put in place to reduce the spread of another respiratory disease, coronavirus disease 2019 (COVID-19). EV-D68 is in the same virus family as polio, and one of the most concerning findings from these outbreaks is that EV-D68 cases were strongly correlated to cases of paralysis, typically in the upper limbs of infected children.
There are currently no recommended antiviral drugs or vaccines to fight EV-D68 infection. We evaluated six different antiviral compounds and determined their activity in cells against EV-D68. We found that Enviroxime, EIDD-1931, and NITD008 limited the ability of EV-D68 to replicate and cause cell death. We also characterized EV-D68 in a mouse model of infection to provide insights into the neurological disease caused by EV-D68. EV-D68 caused death and paralysis in 4-7-day old immunocompromised mice. Virus was detected in leg muscle, spinal cord, and lung tissues of infected mice. We evaluated EIDD-1931 and IVIg in our EV-D68 mouse model and found both treatments significantly reduced mortality mice. Treatment with IVIg was also able to significantly reduce paralysis in EV-D68-infected mice.
Taylor, Zoe K., "Characterization of Enterovirus D68 in a Mouse Model and Evaluation of Antiviral Therapies" (2023). All Graduate Theses and Dissertations, Fall 2023 to Present. 18.
Copyright for this work is retained by the student. If you have any questions regarding the inclusion of this work in the Digital Commons, please email us at .